Zyversa Therapeutics Inc.

08/06/2025 | Press release | Distributed by Public on 08/07/2025 04:09

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 6, 2025 4:30 P.M.
Form: S-1
CIK: 0001859007
Company Name: ZyVersa Therapeutics, Inc.
File Number: 333-288470
Zyversa Therapeutics Inc. published this content on August 06, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on August 07, 2025 at 10:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]